alexa The future of cancer therapy: selecting patients likely to respond to PD1 L1 blockade.
Oncology

Oncology

Journal of Oncology Translational Research

Author(s): Ribas A, Tumeh PC, Ribas A, Tumeh PC

Abstract Share this page

Abstract It is conceivable that, in the near future, an assay that defines the likelihood of a patient with advanced cancer to respond to immunotherapy based on PD1/L1 blockade will be the initial decision point to select the treatment of patients with any cancer type. ©2014 American Association for Cancer Research.
This article was published in Clin Cancer Res and referenced in Journal of Oncology Translational Research

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords